Fear of Progression, Anxiety, and Depression in Patients With Advanced Melanoma in the COVID-19 and Post-COVID-19 Era

Overview

Journal Front Psychiatry

Specialty Psychiatry

Date 2022 May 13

PMID 35558429

Authors

Xiaowen Wang

Min Li

Qiong Shi

Hongchen Ji

Shengnan Kong

Lei Zhu

Hong-Mei Zhang

Affiliations

Soon will be listed here.

Abstract

Background: The novel coronavirus disease 2019 (COVID-19) pandemic causes great disruption to cancer care services, which might bring about psychological problems and further lower both physical and mental life quality in cancer patients. Until now, very few studies focused on the psychological distress of patients with advanced melanoma before or during the epidemic. This study aimed to elucidate the fear of progression (FoP), anxiety, depression, and related independent predictors in patients with advanced melanoma during the COVID-19 outbreak.

Methods: Two hundred and seventy-three patients with unresectable stage III or metastatic melanoma were recruited from February 2020 to November 2021, and completed the Fear of Progression Questionnaire-Short Form (FoP-Q-SF), State Trait Anxiety Inventory (STAI-6), and Patient Health Questionnaire (PHQ-9).

Results: One hundred and seventy-four (64.7%) patients experienced heighted FoP (FoP-Q-SF: 39.9 ± 11.0), 198 (72.5%) patients reported elevated anxiety (STAI-6: 13.1 ± 3.0), and 62 (22.7%) patients had increased depression (PHQ-9: 6.4 ± 6.1). In multivariate analysis, illness duration ( = 0.987 for FoP; = 0.984 for depression), cancer stage ( = 14.394 for anxiety) and disease progression ( = 1.960 for FoP; = 23.235 for anxiety; = 1.930 for depression) were independent predictors for FoP, anxiety or depression. Additionally, the high levels of FoP, anxiety and depression were significantly positive correlated with each other ( = 0.466 for FoP and anxiety; = 0.382 for FoP and depression; = 0.309 for anxiety and depression).

Conclusion: Our study indicates that FoP, anxiety and depression are persisting among patients with advanced melanoma in the COVID-19 and post-COVID-19 era. Effective psycho-oncological interventions are needed for melanoma patients with psychological distress during the ongoing COVID-19 pandemic.

Citing Articles

Fear of progression and quality of life in patients with heart failure: a cross-sectional study on the multiple mediation of psychological distress and resilience.

Chen C, Sun X, Zhang Y, Xie H, Kou J, Zhang H BMC Nurs. 2025; 24(1):60.

PMID: 39825270 PMC: 11742502. DOI: 10.1186/s12912-025-02688-8.

The association between fear of progression and medical coping strategies among people living with HIV: a cross-sectional study.

Li B, Lin X, Chen S, Qian Z, Wu H, Liao G BMC Public Health. 2024; 24(1):440.

PMID: 38347483 PMC: 10860317. DOI: 10.1186/s12889-024-17969-1.

The 31-Gene Expression Profile Test Outperforms AJCC in Stratifying Risk of Recurrence in Patients with Stage I Cutaneous Melanoma.

Podlipnik S, Martin B, Morgan-Linnell S, Bailey C, Siegel J, Petkov V Cancers (Basel). 2024; 16(2).

PMID: 38254778 PMC: 10814308. DOI: 10.3390/cancers16020287.

Prioritizing Melanoma Surgeries to Prevent Wait Time Delays and Upstaging of Melanoma during the COVID-19 Pandemic.

Aw K, Lau R, Nessim C Curr Oncol. 2023; 30(9):8328-8337.

PMID: 37754519 PMC: 10528302. DOI: 10.3390/curroncol30090604.

Kim H, Ji W, Lee J, Jo M, Yun S, Lee S J Korean Med Sci. 2023; 38(31):e236.

PMID: 37550804 PMC: 10412036. DOI: 10.3346/jkms.2023.38.e236.

References

Dieng M, Butow P, Costa D, Morton R, Menzies S, Mireskandari S . Psychoeducational Intervention to Reduce Fear of Cancer Recurrence in People at High Risk of Developing Another Primary Melanoma: Results of a Randomized Controlled Trial. J Clin Oncol. 2016; 34(36):4405-4414. DOI: 10.1200/JCO.2016.68.2278. View

Kim S, Kim S . Do COVID-19-Related Treatment Changes Influence Fear of Cancer Recurrence, Anxiety, and Depression in Breast Cancer Patients?. Cancer Nurs. 2021; 45(2):E628-E638. DOI: 10.1097/NCC.0000000000000937. View

van Not O, van Breeschoten J, van den Eertwegh A, Hilarius D, de Meza M, Haanen J . The unfavorable effects of COVID-19 on Dutch advanced melanoma care. Int J Cancer. 2021; 150(5):816-824. PMC: 8652896. DOI: 10.1002/ijc.33833. View

Wang Y, Duan Z, Ma Z, Mao Y, Li X, Wilson A . Epidemiology of mental health problems among patients with cancer during COVID-19 pandemic. Transl Psychiatry. 2020; 10(1):263. PMC: 7393344. DOI: 10.1038/s41398-020-00950-y. View

Zhu L, Ranchor A, van der Lee M, Garssen B, Almansa J, Sanderman R . Co-morbidity of depression, anxiety and fatigue in cancer patients receiving psychological care. Psychooncology. 2016; 26(4):444-451. DOI: 10.1002/pon.4153. View

Beatty L, Koczwara B, Wade T . Evaluating the efficacy of a self-guided Web-based CBT intervention for reducing cancer-distress: a randomised controlled trial. Support Care Cancer. 2015; 24(3):1043-51. DOI: 10.1007/s00520-015-2867-6. View

Schuermeyer I, Maican A, Sharp R, Bena J, Triozzi P, Singh A . Depression, Anxiety, and Regret Before and After Testing to Estimate Uveal Melanoma Prognosis. JAMA Ophthalmol. 2015; 134(1):51-6. DOI: 10.1001/jamaophthalmol.2015.4343. View

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. PMC: 7159086. DOI: 10.1016/S0140-6736(20)30251-8. View

Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z . Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak. Cancer Discov. 2020; 10(6):783-791. PMC: 7309152. DOI: 10.1158/2159-8290.CD-20-0422. View

10.

Emanuel E, Persad G, Upshur R, Thome B, Parker M, Glickman A . Fair Allocation of Scarce Medical Resources in the Time of Covid-19. N Engl J Med. 2020; 382(21):2049-2055. DOI: 10.1056/NEJMsb2005114. View

11.

Hinz A, Mehnert A, Kocalevent R, Brahler E, Forkmann T, Singer S . Assessment of depression severity with the PHQ-9 in cancer patients and in the general population. BMC Psychiatry. 2016; 16:22. PMC: 4736493. DOI: 10.1186/s12888-016-0728-6. View

12.

Brown S, Fisher P, Hope-Stone L, Hussain R, Heimann H, Damato B . Predictors of long-term anxiety and depression in uveal melanoma survivors: A cross-lagged five-year analysis. Psychooncology. 2020; 29(11):1864-1873. DOI: 10.1002/pon.5514. View

13.

Wagner T, Augustin M, Blome C, Forschner A, Garbe C, Gutzmer R . Fear of cancer progression in patients with stage IA malignant melanoma. Eur J Cancer Care (Engl). 2018; 27(5):e12901. DOI: 10.1111/ecc.12901. View

14.

Xie J, Qi W, Cao L, Tan Y, Huang J, Gu X . Predictors for Fear of Cancer Recurrence in Breast Cancer Patients Referred to Radiation Therapy During the COVID-19 Pandemic: A Multi-Center Cross-Section Survey. Front Oncol. 2021; 11:650766. PMC: 8351463. DOI: 10.3389/fonc.2021.650766. View

15.

Torres-Collado A, Knott J, Jazirehi A . Reversal of Resistance in Targeted Therapy of Metastatic Melanoma: Lessons Learned from Vemurafenib (BRAF-Specific Inhibitor). Cancers (Basel). 2018; 10(6). PMC: 6025215. DOI: 10.3390/cancers10060157. View

16.

Linden W, Vodermaier A, Mackenzie R, Greig D . Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord. 2012; 141(2-3):343-51. DOI: 10.1016/j.jad.2012.03.025. View

17.

You B, Ravaud A, Canivet A, Ganem G, Giraud P, Guimbaud R . The official French guidelines to protect patients with cancer against SARS-CoV-2 infection. Lancet Oncol. 2020; 21(5):619-621. PMC: 7118635. DOI: 10.1016/S1470-2045(20)30204-7. View

18.

Wang Z, Wang J, He J . Active and Effective Measures for the Care of Patients With Cancer During the COVID-19 Spread in China. JAMA Oncol. 2020; 6(5):631-632. DOI: 10.1001/jamaoncol.2020.1198. View

19.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

20.

Tejera-Vaquerizo A, Paradela S, Toll A, Santos-Juanes J, Jaka A, Lopez A . Effects of COVID-19 Lockdown on Tumour Burden of Melanoma and Cutaneous Squamous Cell Carcinoma. Acta Derm Venereol. 2021; 101(8):adv00525. PMC: 9413778. DOI: 10.2340/00015555-3890. View